---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-132248"
form_type: "8-K"
ticker: "ORGO"
cik: "0001661181"
company_name: "Organogenesis Holdings Inc."
filed_at: "2024-12-02T23:59:59+00:00"
generated_at: "2026-05-29T11:24:50.016640+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Organogenesis repurchases 500K shares from director trust at $4.057/sh for $2M total

## Summary
- Repurchase of 500,000 shares from GN 2016 Family Trust (related to director Glenn Nussdorf) at $4.057/share, total $2.03M.
- Price based on 10-day trailing VWAP of common stock as of Nov 26, 2024.
- Repurchase approved by Audit Committee and a Transaction Committee of the Board due to related-party nature.
- Funded by proceeds from Nov 12, 2024 sale of Series A Convertible Preferred Stock to Avista Healthcare Partners.
- Closing expected on or around December 3, 2024.

## SEC filing metadata
- accession: 0000950170-24-132248
- form_type: 8-K
- ticker: ORGO
- cik: 0001661181
- company_name: Organogenesis Holdings Inc.
- filed_at: 2024-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661181/000095017024132248/0000950170-24-132248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661181/000095017024132248/orgo-20241127.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-132248
- JSON: https://secwatch.observer/filing/0000950170-24-132248.json
- Plain text: https://secwatch.observer/filing/0000950170-24-132248.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.